Search Results for:
-
ALPHA-BETA BEGINS FIRST TRIALS
said its first product has entered clinical trials to treat and suppress infections related to upper- abdominal surgery and cancer chemotherapy...Funds will be used for Betafactin clinical trials, developing orally active formulations of PGG for treatment of chronic infections, development of new carbohydrate molecules that treat inflammatory diseases by targeting the b-glucan receptor, and construction of a second pilot plant for production of future Cholestran products. -- Kris Herbst BioWorldBioWorld Today | Wednesday, January 15, 1992 -
ROBERTS TO BUY TRIALS MANAGEMENT COMPANY
said Tuesday that it has entered into a letter of intent to acquire for $6.25 million National Clinical Research Centers Inc., a clinical trials management companyBioWorld Today | Wednesday, January 15, 1992 -
MEDAREX FILES IND FOR MAb
Medarex expects early in the year to begin Phase I/II clinical trials of the drug as an adjunct to chemotherapyBioWorld Today | Tuesday, January 14, 1992 -
DNX PIGS WITH MORE HUMAN HEMOGLOBIN
The Oxford company will also begin this year clinical trials of BB-94, a small molecule drug that inhibits matrix metalloproteinase enzymes responsible for the spread of cancer...Cephalon Inc. (NASDAQ:CEPH) of West Chester, Pa., will file in June to begin clinical trials of its Myotrophin recombinant insulin-like growth factor-1 for amyotrophic lateral sclerosisBioWorld Today | Friday, January 10, 1992 -
MATRIX FILES FOR 2.5 MILLION-SHARE IPO
The company has begun clinical trials of an injectable product for treating solid tumors and surface skin lesions that contains a protein matrix, formulated with chemotherapeutic drugs and a tissue modifier that is a vasoconstrictor, said Craig McMullen, president and chief executive officerBioWorld Today | Friday, January 10, 1992 -
GENSIA, SANDOZ TO PURSUE DIABETES DRUGS
The East Hanover, N.J., company will have an exclusive worldwide license to drugs discovered under the agreement and will be responsible for preclinical development, clinical trials, regulatory filings, manufacturing and marketingBioWorld Today | Thursday, January 9, 1992 -
IMMUNOMEDICS TO GET BROAD PATENT
The company is conducting clinical trials of two therapies, for colorectal cancer and lymphoma, that deliver radioactive antibodies through the bloodstream to the cancers...She could not predict when Immunomedics would begin clinical trials of a cytokine- antibody combinationBioWorld Today | Thursday, January 9, 1992 -
NOVA GETS PATENT FOR LEUMEDIN COMPOUNDS
The patent covers Nova's NPC 15199, which is in clinical trials for contact dermatitis, and NPC 15669, for which the company filed in December to begin trials as a sepsis treatmentBioWorld Today | Thursday, January 9, 1992 -
GLYCOMED RECEIVES PATENT NOTICE
Last week the Alameda, Calif., company (NASDAQ:GLYC) announced it had won an orphan drug designation for Galardin and expects to file in mid-1992 to start clinical trialsBioWorld Today | Thursday, January 9, 1992 -
IMRE ARTHRITIS TREATMENT TRIALS APPROVED
on Wednesday said it has received Food and Drug Administration approval to begin clinical trials of its Prosorba column for treatment of patients with rheumatoid arthritisBioWorld Today | Thursday, January 9, 1992 -
IMMUNEX PRESIDENT PREDICTS LOWER EARNINGS
The company will also begin clinical trials in midyear of tumor necrosis factor in septic shock and cachexia...To support an approval, the company also will begin a large clinical trial this year or next using conventional end pointsBioWorld Today | Tuesday, January 7, 1992 -
PDGF SHOWS PROMISE AGAINST BEDSORES
The first clinical trial of Amgen Inc.'s platelet-derived growth factor (PDGF) shows the recombinant protein can help heal bedsoresBioWorld Today | Tuesday, January 7, 1992 -
THE YEAR AHEAD: MARKET SUCCESS WON'T DETER DEALS
The 24 smaller companies she tracks each have about $40 million to $45 million in cash, and they will need more money as they head into clinical trials...Several biotech companies are now showing that they can move products through clinical trials for well under $100 million, he saidBioWorld Today | Tuesday, January 7, 1992 -
FDA'S FAST TRACK: APPROACH WITH CAUTION
And Burlington noted that the FDA already has taken some steps to accelerate approvals by using "a more forgiving approach" to the use of some surrogate markers in clinical trialsBioWorld Today | Thursday, December 26, 1991 -
ATS FILES FOR 2 MILLION-SHARE OFFERING
In November, the Food and Drug Administration approved expansion of ATS' clinical trials of Dermagraft, a living dermal replacement for use in burn treatment, to 24 burn centersBioWorld Today | Thursday, December 26, 1991 -
CHIEF SCIENTIFIC OFFICER LEAVES LIDAK
At the meeting, according to Katz, the directors also accepted another consultant's recommendation that the company proceed with clinical trials of Lidakol and consider submitting an additional investigational new drug application for the topical application of Lidakol to burnsBioWorld Today | Monday, December 23, 1991 -
COSTS CUT BY REDUCING CEREDASE DOSES
Only a formal clinical trial comparing a low dose with a high dose in patients who have undergone splenectomy will prove that the burden and disruption of three treatments per week are truly worthwhile," the NIH group and colleagues at Massachusetts General Hospital concludedBioWorld Today | Thursday, December 19, 1991 -
ALLELIX RAISES $21.8 MILLION IN IPO
The Mississauga, Ontario, developer of products for tissue repair and inflammation said the money would be used primarily for preclinical product development, clinical trials and construction of a pilot production facilityBioWorld Today | Thursday, December 19, 1991 -
DEPRENYL SEEKS APPROVAL FOR PHASE II
has filed for Canadian approval to begin testing a drug for Alzheimer's disease in two clinical trialsBioWorld Today | Thursday, December 19, 1991 -
JOINT VENTURE FOR HEPATITIS B TRIALS
said its Asian licensee, SciClone Pharmaceuticals Inc., has formed a joint venture company to launch a Phase III clinical trial of Thymosin alpha 1 to treat chronic hepatitis BBioWorld Today | Thursday, December 19, 1991
Category
Current Filters
- xclinical trials
Related Keywords
Categories
- x BioWorld Today (9744)
- x BioWorld International (1951)
- x BioWorld Insight (1198)
- x Bio Perspectives (295)
- x State of the Industry Report (131)
- x BioWorld Genomics Review (58)
- x Top 25 Drug Report (43)
- x BioWorld Snapshots (29)
- x Biotech Innovations (17)
- x Market-Leading Biotech Drugs (12)
- x RNAi Report (11)
- x BioWorld Phase III Report (7)
- x Executive Compensation Report (4)
- x Recorded (4)
BioWorld | 3525 Piedmont Road
Building 6, Suite 400 | Atlanta, Georgia 30305, USA
Building 6, Suite 400 | Atlanta, Georgia 30305, USA
Part of Thompson Media Group LLC
Free Ezine
Sign up for Perspectives FREE e-mail newsletter.
Customer Service: In the U.S. and Canada: 1-800-477-6307
Outside the U.S.: 1-404-262-5423
customerservice@bioworld.com
Hours: Monday - Thursday, 8:30 am - 6:00 pm EST
Friday, 8:30am - 4:30 pm EST
Outside the U.S.: 1-404-262-5423
customerservice@bioworld.com
Hours: Monday - Thursday, 8:30 am - 6:00 pm EST
Friday, 8:30am - 4:30 pm EST
Copyright @ 2013 AHC Media. Reproduction, reposting content is strictly prohibited.